Clinical Trial Update: Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD [NA]

View source ↗

Summary

A clinical trial evaluating a percutaneous right ventricular assist device (RVAD) to preemptively treat right heart failure after LVAD implantation was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Heart Failure | NA | Status: TERMINATED | Results posted: 2024-07-09